NCT05194111: Treating Heart Dysfunction Related to Cancer Therapy With Sacubitril/Valsartan
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 70 planned
- Started
- 11 Aug 2022
- Primary completion
- 30 Nov 2028
- Arms
- Arm 2: Valsartan
- Results
- None posted
- 18 Jan 2022: Trial registered
- 11 Aug 2022: Trial started